Down Syndrome-Associated Alzheimer's Disease (DS-AD)
1 clinical trials · Condition
◉ Watch Down Syndrome-Associated Alzheimer's Disease (DS-AD)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD) (NCT07636811) | Alnylam Pharmaceuticals | 2026-08-31 |
Track Down Syndrome-Associated Alzheimer's Disease (DS-AD) automatically
Every clearance here is in the API, with alerts when new ones post.